This procurement opportunity involves establishing a framework agreement for the supply of antithrombotic medications, specifically Enoxaparin sodium, under the brand name CLEXANE. The required products include pre-filled syringes in various dosages, such as CLEXANE FORTE and other formulations. The
Contract awarded. Originally published 10 months ago.
Supply non-clinical consumables including forms, labels, and packaging for pathology and primary care services.
Procurement of RSV immunisation vaccine products for adult populations, scheduled for 2028.
Procurement for meningococcal ACWY vaccine supply in 2027 from qualified manufacturers or distributors.
Procurement opportunity for MMR vaccine supply with anticipated delivery timeline of 2027.
